Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by skyhawk1on May 01, 2020 2:54am

83 Views

Post# 30974789

RE:RE:RE:RE:RE:RE:But Orange Man Bad!

Great post Pan! I didn't read ur post or I would have not bothered?! Heheh ~ I guess "great minds think alike" in the middle of the night eh?! LOL

Pandora wrote:

enriquesuave wrote: Over the last 60 years 100s of millions of doses of HCQ have been used. CDC says safe to use in Adults children and pregnant and nursing women. No dose limiting toxicity. May make psoriasis worse is the only caution and high doses used for many years may cause eye retinal problems . Hypocrisy is rampant in politics. If it can reduce hospitalisations and death by treating early, then why not use it. WHO lists HCQ in list of essential medicines.

It just seems a little strange how much Fauci, head of NIH, is pushing the Remdevisir when their results are shaky and yet he keeps suppressing the HCQ until completion of a full controlled study on a drug that has been in use for 60 years and has exhibited good results in many locations around the world.

Also I heard a report today that said Gilead donates between $5 and $10 million to NIH - not sure if that was for 1 year or 2 years. But I'm sure that would have no bearing on priorities.